Insight Molecular Diagnostics Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -113.2% | -113.2% | -77.3% |
| FY2017 | -440.0% | -308.9% | -189.7% |
| FY2018 | -460.2% | -460.2% | -165.5% |
| FY2019 | -72.7% | -72.7% | -56.3% |
| FY2020 | -89.4% | -89.4% | -54.0% |
| FY2021 | -98.3% | -98.3% | -40.2% |
| FY2022 | -212.6% | -212.6% | -72.8% |
| FY2023 | -135.7% | -135.7% | -37.1% |
| FY2024 | 494.2% | 494.2% | -172.9% |
| FY2025 | 159.6% | 159.6% | -195.0% |